https://scholars.lib.ntu.edu.tw/handle/123456789/520514
標題: | Angiotensin-converting enzyme inhibitor/angiotensin II receptor blockers and pneumonia risk among stroke patients | 作者: | Liu C.-L. Shau W.-Y. CHI-SHIN WU Lai M.-S. |
關鍵字: | angiotensin II receptor blockers; angiotensin-converting enzyme inhibitors; case-crossover study; pneumonia; stroke | 公開日期: | 2012 | 卷: | 30 | 期: | 11 | 起(迄)頁: | 2223-2229 | 來源出版物: | Journal of Hypertension | 摘要: | OBJECTIVE: To investigate the effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on pneumonia hospitalization in patients with stroke history in Taiwan. METHODS: We conducted a case-crossover study using the National Health Insurance Research Database in Taiwan during the period from 1998 to 2007. Patients who had stroke history and were subsequently admitted for pneumonia were enrolled for analysis. The status of exposure to angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers 1-30 days prior to admission (case period) was compared to that during 91-120 days and 181-210 days before admission (control periods) for each patient. Conditional logistic regression was used to estimate the odds ratio (OR) and 95% confidence interval (95% CI) for the association between pneumonia and use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers. RESULTS: In this study, 13 832 patients with incident pneumonia from the stroke patient population were enrolled. After adjustment for time-varying confounding factors, angiotensin-converting enzyme inhibitor use was associated with a decreased pneumonia risk (OR 0.70; 95% CI 0.68-0.87) and a significant dose-response relationship (P < 0.01). The pneumonia risk associated with angiotensin II receptor blockers use was not significant (OR 1.02; 95% CI 0.87-1.19). CONCLUSIONS: Our study revealed a significant protective effect with dose-response relationship of angiotensin-converting enzyme inhibitor use on hospitalization for pneumonia among stroke patients. Further studies to confirm the protective effect of angiotensin-converting enzyme inhibitor use on pneumonia risk are warranted. Copyright ? 2012 Lippincott Williams &Wilkins. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84867744876&doi=10.1097%2fHJH.0b013e328357a87a&partnerID=40&md5=7afdf4eff92eee4e82b07017a53951fa https://scholars.lib.ntu.edu.tw/handle/123456789/520514 |
ISSN: | 0263-6352 | DOI: | 10.1097/HJH.0b013e328357a87a | SDG/關鍵字: | angiotensin receptor antagonist; dipeptidyl carboxypeptidase inhibitor; aged; article; cerebrovascular accident; confidence interval; controlled study; crossover procedure; dose response; female; human; major clinical study; male; pneumonia; priority journal; risk factor |
顯示於: | 流行病學與預防醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。